文献速递免疫规划传染病防控与疫情报告

HPV多队列疫苗接种的影响:HPV相关疾病发病率更快控制的真实世界证据

The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity.
PubMed 文献 · Vaccine · 2020-01-06

挪威和丹麦于2009年对12岁女孩启动四价HPV疫苗常规接种,丹麦另于2008年对较大年龄组开展免费多队列接种。研究链接两国2006-2015年国家登记数据,发现丹麦女性生殖器疣发病率年降18.0%,挪威仅降4.8%,结论为高覆盖率多队列接种可快速降低HPV相关疾病负担。

要点

  • 丹麦多队列接种后男女各年龄组生殖器疣发病率快速下降,挪威仅 modest 下降。
  • 2015年12-35岁女性四价HPV疫苗总覆盖率挪威24%、丹麦70%。
  • 仅接种12岁单一年龄组队列将推迟HPV相关疾病控制至少十年。

核心结论

  • 高覆盖率多队列疫苗接种可实现HPV相关疾病的快速下降。
  • 仅接种12岁女孩单一队列将推迟HPV相关疾病控制至少十年。
  • 计划开展HPV疫苗接种的国家也应启动多队列接种以更快控制疾病。

研究设计与样本

  • 通过国家个人标识符链接挪威和丹麦多个全国健康登记库,获取2006-2015年12-35岁男女生殖器疣发病和四价HPV疫苗接种数据。
  • 计算年龄别和年龄标化生殖器疣发病率、疫苗接种前后(2006-2009年与2009-2015年)发病率趋势及女性疫苗覆盖率。

主要发现

  • 研究期间挪威和丹麦合计生殖器疣 incident 病例超过200,000例,超过710,000名女孩至少接种一剂四价HPV疫苗。
  • 2015年12-35岁女性四价HPV疫苗总覆盖率挪威为24%、丹麦为70%。
  • 2009-2015年女性生殖器疣发病率年降幅挪威为4.8%(95%CI:4.3至5.3)、丹麦为18.0%(95%CI:17.5至18.6)。
  • 2009-2015年男性生殖器疣发病率年降幅挪威为1.9%(95%CI:1.4至2.4)、丹麦为10.7%(95%CI:10.3至11.2)。
  • 丹麦接种后男女及各年龄组生殖器疣发病率快速下降,挪威仅表现为 modest 下降。

临床怎么用

  • 作者认为,计划开展HPV疫苗接种的国家也应启动多队列接种以更快控制疾病。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2009, both Norway and Denmark initiated routine quadrivalent human papillomavirus vaccination (qHPV) for 12-year-old girls; however, Denmark also introduced free-of-charge multi-cohort vaccination for older age groups in 2008. We aim to describe trends in genital warts (GWs) incidence rates (IRs) among men and women and qHPV vaccine coverage among women in Norway and Denmark in 2006-2015. METHODS: We linked multiple national health registries in Norway and Denmark via national personal identifiers to access data on GWs incidence and qHPV vaccination among women and men aged 12-35 years residing in Norway and Denmark in 2006-2015. We calculated age-specific and age-standardized GWs IRs, GWs IR trends before (2006-2009) and after (2009-2015) the implementation of qHPV vaccination, and qHPV vaccine coverage among women. RESULTS: In Norway and Denmark together, there were more than 200,000 cases of incident GWs and over 710,000 girls got at least one dose of qHPV vaccine during the study period. The total qHPV coverage in Norway and Denmark in 2015 was among women aged 12-35 years 24% and 70%, respectively. GWs IRs in Norway and Denmark decreased annually in 2009-2015 among women by 4.8% (95% confidence interval: 4.3 to 5.3) and 18.0% (95%CI: 17.5 to 18.6), respectively, and among men 1.9% (95%CI: 1.4 to 2.4) and 10.7% (95%CI: 10.3 to 11.2), respectively. In Denmark, GWs IRs decreased rapidly among both sexes and all age groups after qHPV vaccination, while Norway showed only a modest decrease. CONCLUSION: Rapid decline in HPV-related morbidity is feasible with high coverage of multi-cohort vaccination. However, the decision to vaccinate a single cohort of 12-years-old girls only will postpone HPV-related disease control by at least a decade. Thus countries planning HPV vaccination programs should also initiate multi-cohort vaccination for faster disease control.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Orumaa M, Kjaer SK, Dehlendorff C, et al. The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity. Vaccine. 2020. PMID: 31917039. doi:10.1016/j.vaccine.2019.12.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。